BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Yubing TaoFei WangXiaopei ShenGuangwu ZhuRengyun LiuDavid ViolaRossella EliseiEfisio PuxedduLaura FugazzolaCarla ColomboBarbara JarzabAgnieszka CzarnieckaAlfred K LamCaterina MianFederica VianelloLinwah YipGarcilaso Riesco-EizaguirrePilar SantistebanChristine J O'NeillMark S SywakRoderick Clifton-BlighBela BendlovaVlasta SýkorováShihua ZhaoYangang WangMingzhao XingPublished in: The Journal of clinical endocrinology and metabolism (2021)
LNM-associated mortality risk is sharply differentiated by the BRAF status in PTC; in CPTC, LNM showed no increased mortality risk with wild-type BRAF but a robust one with BRAF mutation. These results have strong clinical relevance.